- Impax Laboratories, Inc.(NASDAQ:IPXL) today confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc.
in connection with its WELCHOL (Colesevelam HCl) tablets, 625 mg.
Impax filed its Abbreviated New Drug Application ...